Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.85 - $1.41 $351,273 - $582,700
-413,263 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.16 - $2.5 $1.56 Million - $3.36 Million
-1,342,516 Reduced 76.46%
413,263 $546,000
Q4 2021

Feb 14, 2022

BUY
$2.46 - $8.74 $4.32 Million - $15.3 Million
1,755,779 New
1,755,779 $4.32 Million
Q3 2021

Nov 15, 2021

SELL
$5.1 - $9.39 $371,458 - $683,920
-72,835 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$3.95 - $6.88 $493,125 - $858,912
-124,842 Reduced 63.15%
72,835 $466,000
Q1 2021

May 17, 2021

BUY
$2.01 - $5.55 $397,330 - $1.1 Million
197,677 New
197,677 $878,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $93.7M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.